P Russo, E Tacconelli, PP Olimpieri, S Celant… - Viruses, 2022 - ncbi.nlm.nih.gov
Remdesivir is the first drug approved for treatment of COVID-19 but current evidence for
recommending its use for the treatment of moderate-to-severe disease is still controversial …